{"id":"W2794417831","doi":"10.1002/cpt.1004","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Children's Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; Canada Foundation for Innovation; National Institute of Allergy and Infectious Diseases; Australian Centre for HIV and Hepatitis Virology Research","keywords":"Oxcarbazepine; Carbamazepine; Toxic epidermal necrolysis; Pharmacogenetics; Medicine; Genotype; Allele; Eosinophilia; Pharmacology; Guideline; Human leukocyte antigen; Epilepsy; Immunology; Dermatology; Genetics; Psychiatry; Biology; Pathology; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007324557,0.0009484022,0.002250835,0.00225524,0.0005542701,0.001892331,0.003200826,0.003913201,0.008214979],"category_scores_gemma":[0.02326095,0.0005891229,0.002292796,0.002677631,0.0005751476,0.001448991,0.001569549,0.005639199,0.006325285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001497296,"about_ca_system_score_gemma":0.006192274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01166211,"about_ca_topic_score_gemma":0.01876823,"domain_scores_codex":[0.9916795,0.003011077,0.002625019,0.0003196552,0.00207208,0.0002926191],"domain_scores_gemma":[0.9783176,0.007512697,0.003526467,0.0006267002,0.009155809,0.0008605988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001640006,0.0002557163,0.002981763,0.002770898,0.0001599806,0.0004719974,0.0001475128,0.000662609,0.0007787902,0.002352218,0.5980074,0.3912471],"study_design_scores_gemma":[0.000537295,0.0002058946,0.01537997,0.01492924,0.0005947697,0.002334428,0.0002193615,0.001116007,0.001119162,0.005003336,0.9584695,0.00009101229],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.008621285,0.3840768,0.06136727,0.3335262,0.01346487,0.004064782,0.02263063,0.004409736,0.1678384],"genre_scores_gemma":[0.0530404,0.4731732,0.1724439,0.1690458,0.0121116,0.0095182,0.0581176,0.001534664,0.05101459],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.01166211,"threshold_uncertainty_score":0.03873646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1847197132860234,"score_gpt":0.5213460437019938,"score_spread":0.3366263304159705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}